"Mercy Health - Cancer Center in Elyria, Ohio is one of Mercy Health's many Cancer Care and Oncology locations serving communities across Ohio and Kentucky."

During the past decade, Community Cancer Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 41 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 7 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Community Cancer Center" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 28 trials, followed by "SWOG Cancer Research Network" with 8 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 4 trials sponsored, "Eastern Cooperative Oncology Group" with 4 trials sponsored and "NSABP Foundation Inc" with 4 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Community Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 48 trials as a collaborator, "Cancer and Leukemia Group B" with 3 trials as a collaborator, "Bristol-Myers Squibb" with 2 trials as a collaborator, "NRG Oncology" with 2 trials as a collaborator and "SWOG Cancer Research Network" with 2 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Community Cancer Center" are "Breast Cancer" (12 trials), "Lung Cancer" (6 trials), "Unspecified Adult Solid Tumor, Protocol Specific" (6 trials), "Colorectal Cancer" (4 trials) and "Lymphoma" (4 trials). Many other conditions were trialed in "Community Cancer Center" in a lesser frequency.

Most popular intervention types in "Community Cancer Center" are "Drug" (37 trials), "Other" (18 trials), "Biological" (17 trials), "Radiation" (8 trials) and "Procedure" (5 trials). Other intervention types were less common.

The name of intervention was led by "placebo" (12 trials), "bevacizumab" (6 trials), "capecitabine" (5 trials), "cyclophosphamide" (5 trials) and "gemcitabine hydrochloride" (5 trials). Other intervention names were less common.

The vast majority of trials in "Community Cancer Center" are 40 trials for "All" genders, 6 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Community Cancer Center". undefined are not yet recruiting, undefined are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 38 completed trials in Community Cancer Center, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Community Cancer Center, 2 "Phase 1" clinical trials were conducted, 23 "Phase 2" clinical trials and 18 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".